PROPRANOLOL Drug Patent Profile
✉ Email this page to a colleague
When do Propranolol patents expire, and when can generic versions of Propranolol launch?
Propranolol is a drug marketed by Actavis Elizabeth, Adare Pharms Inc, Amta, Anda Repository, Extrovis, Inwood Labs, Ipca Labs Ltd, Lupin, Upsher Smith Labs, Zydus Pharms Usa Inc, Allied, Baxter Hlthcare Corp, Chartwell Injectable, Fresenius Kabi Usa, Hikma Farmaceutica, Smith And Nephew, Solopak, Hikma, Pai Holdings Pharm, Aiping Pharm Inc, Ani Pharms, Chartwell Rx, Dava Pharms Inc, Duramed Pharms Barr, Impax Labs Inc, Innogenix, Interpharm, Ivax Sub Teva Pharms, Lederle, Mankind Pharma, Mylan, Northstar Hlthcare, Ph Health, Purepac Pharm, Roxane, Sandoz, Schering, Superpharm, Teva, Warner Chilcott, Watson Labs, Watson Labs Teva, and Rising. and is included in one hundred and thirty-nine NDAs.
The generic ingredient in PROPRANOLOL is hydrochlorothiazide; propranolol hydrochloride. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; propranolol hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PROPRANOLOL?
- What are the global sales for PROPRANOLOL?
- What is Average Wholesale Price for PROPRANOLOL?
Summary for PROPRANOLOL
| US Patents: | 0 |
| Applicants: | 43 |
| NDAs: | 139 |
| Drug Prices: | Drug price information for PROPRANOLOL |
| Drug Sales Revenues: | Drug sales revenues for PROPRANOLOL |
| DailyMed Link: | PROPRANOLOL at DailyMed |
US Patents and Regulatory Information for PROPRANOLOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Duramed Pharms Barr | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | TABLET;ORAL | 071327-001 | Oct 1, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mankind Pharma | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | TABLET;ORAL | 216663-001 | Jan 27, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Allied | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | INJECTABLE;INJECTION | 076400-001 | Feb 26, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lupin | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 204349-004 | Jan 12, 2024 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
